Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Levin, N. W.
Right arrow Articles by Ronco, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, N. W.
Right arrow Articles by Ronco, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 698-700
© 2001 European Renal Association-European Dialysis and Transplant Association


Editorial Comments

Haemodialysis renal replacement therapy—do we need more research?

Nathan W. Levin and Claudio Ronco

Renal Research Institute, New York, USA

Introduction

The answer to the question is in the affirmative for two reasons. The first can be expressed by the cliché ‘knowledge is power’, since the dialysis world certainly needs more power to deal with the unacceptable morbidity and mortality of the population on all forms of dialysis. The second is the fascination with the myriad of individual pathophysiological problems which tantalize with partially proven hypotheses and potential therapeutic successes. In regard to the second reason, there was a time when dialysis was seen only as an imperfect mode of saving lives, but certainly not worthy of research at the highest academic level. Clearly this is no longer the case. A personal list of items requiring research is briefly discussed, with the strong caveat that enumeration by others would be quite different.

International variations in mortality and morbidity

Reaching . . . [Full Text of this Article]

Cardiovascular disease

Uraemic toxins

Intradialytic treatment quantitation

Haematocrit

Vascular access

‘Dry weight’

Nutrition

Economic analysis and survival

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?